Miller Kirk D, Masur Henry, Jones Elizabeth C, Joe Galen O, Rick Margaret E, Kelly Grace G, Mican JoAnn M, Liu Shuying, Gerber Lynn H, Blackwelder William C, Falloon Judith, Davey Richard T, Polis Michael A, Walker Robert E, Lane H Clifford, Kovacs Joseph A
Critical Care Medicine Department, Clinical Center, Building 10, Room 7D43, MSC1662, National Institutes of Health, Bethesda, MD 20892-1662, USA.
Ann Intern Med. 2002 Jul 2;137(1):17-25. doi: 10.7326/0003-4819-137-1-200207020-00008.
Osteonecrosis has been reported to occur occasionally among HIV-infected patients. The diagnosis of symptomatic osteonecrosis of the hip in two of the authors' patients, together with reports from community physicians, raised a concern that the prevalence of osteonecrosis is increasing.
To determine the prevalence of osteonecrosis of the hip in asymptomatic HIV-infected patients and to identify potential risk factors associated with osteonecrosis.
Survey and comparison study.
The Clinical Center of the U.S. National Institutes of Health.
339 asymptomatic HIV-infected adults (of 364 asked to participate) and 118 age- and sex-matched HIV-negative volunteers enrolled between 1 June and 15 December 1999.
Osteonecrosis of the hip, as documented by magnetic resonance imaging. Data from clinic records and a patient questionnaire administered before magnetic resonance imaging were used in an analysis of risk factors. A subset of patients was evaluated for hypercoagulable state.
Fifteen (4.4% [95% CI, 2.5% to 7.2%]) of 339 HIV-infected participants had osteonecrosis lesions on magnetic resonance imaging, and no HIV-negative participants had similar lesions. Among HIV-infected participants, osteonecrosis occurred more frequently in those who used systemic corticosteroids, lipid-lowering agents, or testosterone; those who exercised routinely by bodybuilding; and those who had detectable levels of anticardiolipin antibodies.
Patients infected with HIV have an unexpectedly high occurrence of osteonecrosis of the hip. Although screening asymptomatic patients is not warranted, HIV-infected patients with persistent groin or hip pain should be evaluated for this debilitating complication.
据报道,骨坏死偶尔会在HIV感染患者中发生。作者的两名患者被诊断为有症状的髋部骨坏死,再加上社区医生的报告,引发了人们对骨坏死患病率正在上升的担忧。
确定无症状HIV感染患者中髋部骨坏死的患病率,并识别与骨坏死相关的潜在危险因素。
调查与比较研究。
美国国立卫生研究院临床中心。
1999年6月1日至12月15日期间招募的339名无症状HIV感染成年人(共邀请364人参与)以及118名年龄和性别匹配的HIV阴性志愿者。
通过磁共振成像记录的髋部骨坏死情况。在分析危险因素时,使用了临床记录数据以及磁共振成像检查前患者问卷的数据。对一部分患者进行了高凝状态评估。
339名HIV感染参与者中有15人(4.4% [95%可信区间,2.5%至7.2%])在磁共振成像上有骨坏死病变,而HIV阴性参与者中没有类似病变。在HIV感染参与者中,骨坏死在使用全身性皮质类固醇、降脂药物或睾酮的患者中更频繁发生;在经常通过健身锻炼的患者中更频繁发生;在抗心磷脂抗体检测呈阳性的患者中更频繁发生。
HIV感染患者髋部骨坏死的发生率出人意料地高。虽然对无症状患者进行筛查并无必要,但对于有持续腹股沟或髋部疼痛的HIV感染患者,应评估是否存在这种使人衰弱的并发症。